Morphosys Ag ADR (MOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MOR | BMY | AMGN | GILD | VRTX |
| Company | Morphosys Ag ADR | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 17.93 | 48.45 | 266.83 | 67.80 | 396.88 |
| High | 17.99 | 48.57 | 267.51 | 67.89 | 396.88 |
| Low | 17.93 | 48.24 | 265.39 | 67.25 | 394.27 |
| Last | 17.98 | 48.38 | 265.51 | 67.42 | 395.58 |
| Change | -0.04 | -0.13 | +0.74 | -0.33 | -1.78 |
| % Change | -0.22% | -0.27% | +0.28% | -0.49% | -0.45% |
| Volume | 7,738 | 361,609 | 74,021 | 197,507 | 27,712 |
| 20-Day Average Volume | 371,783 | 10,943,587 | 2,171,777 | 6,184,376 | 867,317 |
| Previous Close | 18.02 | 48.51 | 265.51 | 67.75 | 397.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.09 | 51.37 | 273.89 | 70.93 | 408.69 |
| 20-Day Raw Stochastic | 17.14% | 2.91% | 7.43% | 0.43% | 6.21% |
| 20-Day Relative Strength | 62.85% | 36.22% | 39.41% | 30.64% | 37.88% |
| Weighted Alpha | +76.93 | -30.15 | +6.13 | -23.43 | +16.44 |
| Today's Opinion | 88% Buy | 56% Sell | 40% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 88% Buy | 56% Sell | 40% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 100% Buy | 8% Sell | 8% Sell | 72% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.27% since 04/09/24 | -6.39% since 04/09/24 | -1.56% since 04/09/24 | -3.75% since 04/09/24 | -2.23% since 04/09/24 |
| Low | 17.93 on 04/16/24 | 48.12 on 04/15/24 | 264.35 on 04/15/24 | 67.29 on 04/16/24 | 393.76 on 04/12/24 |
| High | 18.12 on 04/11/24 | 51.28 on 04/10/24 | 273.00 on 04/11/24 | 69.76 on 04/10/24 | 404.69 on 04/11/24 |
| 1-Month | |||||
| %Chg | +0.50% since 03/15/24 | -7.71% since 03/15/24 | -1.01% since 03/15/24 | -8.64% since 03/15/24 | -2.99% since 03/15/24 |
| Low | 17.87 on 04/03/24 | 48.12 on 04/15/24 | 264.35 on 04/15/24 | 67.29 on 04/16/24 | 393.76 on 04/12/24 |
| High | 18.22 on 03/25/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +66.48% since 01/16/24 | -3.39% since 01/16/24 | -12.30% since 01/16/24 | -21.71% since 01/16/24 | -9.60% since 01/16/24 |
| Low | 8.88 on 01/23/24 | 47.58 on 02/06/24 | 264.35 on 04/15/24 | 67.29 on 04/16/24 | 393.76 on 04/12/24 |
| High | 18.31 on 03/12/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +166.42% since 10/16/23 | -15.51% since 10/16/23 | -7.23% since 10/16/23 | -15.00% since 10/16/23 | +5.74% since 10/16/23 |
| Low | 4.18 on 11/22/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 67.29 on 04/16/24 | 341.90 on 11/16/23 |
| High | 18.31 on 03/12/24 | 57.65 on 10/17/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,714,191 | 98,318,080 | 142,291,856 | 84,353,968 | 102,701,272 |
| Shares Outstanding, K | 150,621 | 2,026,759 | 535,919 | 1,245,077 | 258,459 |
| Annual Sales | 257,890,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -205,350,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 63,610,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | 53,170,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 1.17 | 0.39 | 0.58 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.33 on 03/13/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/01/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.44 | 14.33 | 10.13 | 29.51 |